Results of Patient Education about Osteoporosis after Fragility Fracture: Pharmacist’s Role
Several potential barriers exist to receiving pharmacological treatment for osteoporosis, including patients’ lack of knowledge about osteoporosis (patients may attribute their fragility fractures to factors other than fragile bones, such as “falling the wrong way”). Upon learning that they have osteoporosis, patients may be further deterred from accepting therapy by the cost of treatment, concerns about side effects, and uncertainty about efficacy. Another compliance issue arises because the positive effects of the treatment cannot be subjectively felt, yet adverse effects may occur.
Pharmacists have an excellent opportunity to intervene in the care of patients with fragility fracture and to reduce the care gap. They can educate patients about the risk factors for osteoporosis and suggest pharmacotherapy for general bone health, such as calcium and vitamin D. Pharmacists can also be instrumental in the selection of appropriate prescription treatments for osteoporosis, such as bisphosphonates or raloxifene, and can help to individualize therapies according to the patient’s risk profile and potential for adverse events. Once therapy has been selected, the pharmacist can discuss expectations of the medication with the patient. In addition, a medication review might identify drugs that increase the risk of falls, such as sedatives or hypnotics. Patients should be educated about avoiding or decreasing the use of these medications where possible. Through the provision of pharmaceutical care, pharmacists can help to achieve the following treatment goals of osteoporosis (among others):
cialis 10 mg
• Improving patient understanding of osteoporosis so that they can be involved in decision-making
• Educating patients about medication and assisting with adherence
• Preventing future fractures
• Stabilizing or achieving an increase in bone mass
• Relieving symptoms of fractures and skeletal deformity
• Maximizing physical function and preventing falls
The purpose of this study was to determine if pharmacists could improve patients’ knowledge of osteoporosis and motivate them to reduce their risks for osteoporosis and future fragility fractures.
